First-line nivolumab plus ipilimumab in kidney cancer patients without nephrectomy
A recent post hoc analysis of the CheckMate 214 trial [...]
A recent post hoc analysis of the CheckMate 214 trial [...]
In a recent study, the use of cabozantinib after progression [...]
The Food and Drug administration (FDA) in the USA has [...]
A recent review published in Current Opinion in Supportive and [...]
A recent study looked at the efficacy and safety of [...]
The European Association of Urology (EAU) Guidelines for Renal Cell [...]
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
Treatment of people with intermediate to high risk renal cell [...]
In a study published in Cancer Cell last week, researchers [...]
The use of radiotherapy for the treatment of metastatic renal [...]